Latest News
Inovio Pharmaceuticals, Inc.
- Inovio Pharmaceuticals, Inc. Estimates – NASDAQ:INO
- Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
- Inovio wins USD 80m judgment against VGXI and GeneOne over DNA plasmid supply deal
- Inovio Pharmaceuticals (INO) Awarded $80.4M in Legal Case Amid F
- INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
- Four FDA Decisions in Two Weeks: GSK's Hepatitis B Drug Leads the Pack as Inovio Shares Have Already Fallen Over 40% This Year
- Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
- Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
- Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
- Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Headlines from the last 30 days, linking to the original publishers. See all market news →